Cooperative Pain Education and Self-management: Expanding Treatment for Real-world Access (COPES ExTRA)
CompletedNot applicableNCT03469505
View the official record on ClinicalTrials.gov Recruiting status changes often. Contact the study team listed on ClinicalTrials.gov, and talk to your doctor before joining a study.
This study has no listed site in Canada in this snapshot. It is included as part of the worldwide chronic pain corpus.
Brief summary (from the registry)
To conduct a superiority trial of COPES versus standard Veterans Health Administration (VHA) Cognitive Behavioral Therapy Chronic Pain (CBT-CP)
Study details
- Official title
- Cooperative Pain Education and Self-management: Expanding Treatment for Real-world Access (COPES ExTRA)
- Conditions
- Interventions
- Behavioral: COPES
- Behavioral: CBT-CP
- Sponsor
- Yale University
- Collaborators
- National Center for Complementary and Integrative Health (NCCIH)
- Start date
- 2019-12-20
- Primary completion
- 2025-02-20
- Sex
- All
- Age range
- from 18 Years
- Results posted
- Yes, on ClinicalTrials.gov
- Countries
- United States
- Total sites listed
- 9
Eligibility criteria
Show eligibility criteria (verbatim from the registry)
Inclusion Criteria: * Patients with chronic musculoskeletal pain receiving care in VHA. * A pain-related musculoskeletal diagnosis indicated by an EHR identified ICD-9 or -10 code. * The presence of chronic pain of at least moderate severity with EHR NRS pain scores ≥ 4 in three separate months for a period of 12 months. * Absence of mental illness serious enough to have resulted in an inpatient psychiatric hospitalization in the prior 3 months excluding detoxification of alcohol or drugs. * Absence of malignant cancer diagnosis or receipt of hospice or end-of-life palliative care. * Ability to participate safely in the walking portion of the intervention as evidenced by patient-reported ability to walk at least one block and absence of diabetic foot ulcers at the time of the enrollment. * Absence of significant cognitive impairment as identified by a dementia-related diagnosis. * Availability of a touch-tone land-line or cellular telephone and no vision or hearing deficits that would impair participation verified by patient report at the time of the enrollment call. Exclusion Criteria: * Patients not fitting criteria for inclusion.
Source: ClinicalTrials.gov (US National Library of Medicine), snapshot October 2026. Check the registry for current recruiting status. Record: https://clinicaltrials.gov/study/NCT03469505